New drug trial offers hope for Tough-to-Treat blood cancer
NCT ID NCT04703192
Summary
This study is testing an oral drug called valemetostat in adults whose peripheral T-cell lymphoma has come back or hasn't responded to prior treatments. The main goal is to see if the drug safely shrinks tumors and for how long. It includes 155 participants and focuses on measuring tumor response and side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT T-CELL LEUKEMIA/LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.O.di Bologna Policl.S.Orsola
Bologna, 40138, Italy
-
APHP - Hopital Saint Louis
Paris, 75010, France
-
ASST Papa Giovanni XXIII - Medicina Trasfusionale ed Ematologia - Bergamo
Bergamo, 24127, Italy
-
Asan Medical Center - Oncology
Seoul, 05505, South Korea
-
BC Cancer - Vancouver Centre
Vancouver, British Columbia, V5Z 4E6, Canada
-
CHRU de Lille - Hôpital Claude Huriez - Maladies du Sang
Lille, 59037, France
-
CHU de Dijon
Dijon, 21079, France
-
Centre Hospitalier Lyon Sud - Hématologie
Pierre-Bénite, 69495, France
-
Centre Lyon Berard - Medical Oncology
Lyon, 69008, France
-
Chang Gung Medical Foundation - Kaohsiung Chang Gung Memorial Hospital - Hemato-Oncology
Kaohsiung City, 83301, Taiwan
-
Chang Gung Medical Foundation - LinKou Chang Gung Memorial Hospital - Hematology and Oncology - Hematology and Oncology
Taoyuan, 33305, Taiwan
-
Churchill Hospital
Oxford, OX3 7LE, United Kingdom
-
City Of Hope National Medical Center
Duarte, California, 91010, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Duke Cancer Center
Durham, North Carolina, 27710, United States
-
Emory University Hospital - Winship Cancer Institute
Atlanta, Georgia, 30322, United States
-
Epworth Healthcare
Richmond, 3121, Australia
-
Fondazione Pascale, IRCCS, Istituto Nazionale dei Tumori
Naples, 80131, Italy
-
Hackensack University Medical Center - John Theurer Cancer Center
Hackensack, New Jersey, 07601, United States
-
Hokkaido University Hospital - Medical Oncology Center
Sapporo, Hokkaido, 060-8648, Japan
-
Hospital Universitario Fundación Jiménez Díaz
Madrid, 28040, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hospital Universitario Vall d'Hebrón
Barcelona, 08035, Spain
-
Hospital Universitario Virgen del Rocio
Seville, 41013, Spain
-
Hôpital Necker
Paris, 75015, France
-
ICO Hospital Duran i Reynals
Barcelona, 08029, Spain
-
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole)
Toulouse, 31100, France
-
Kagoshima University Hospital
Kagoshima, 890-8520, Japan
-
Kyushu University Hospital
Fukuoka, 812-0054, Japan
-
Leids Universitair Medisch Centrum (LUMC) (Leiden University Medical Center)
Leiden, 2333ZA, Netherlands
-
Mayo Clinic - Rochester
Rochester, Minnesota, 55901, United States
-
Memorial Sloan-Kettering Cancer Center at Memorial Hospital
New York, New York, 10065, United States
-
Nagasaki University Hospital
Nagasaki, 852-8501, Japan
-
Nagoya City University Hospital
Nagoya, Aichi-ken, 467-8602, Japan
-
National Cancer Center Hospital
Chuo Ku, Tokyo, 104-0045, Japan
-
National Cancer Center Hospital East
Kashiwa, Chiba, 277-8577, Japan
-
National Cheng Kung University Hospital - Internal Medicine
Tainan, 70403, Taiwan
-
National Hospital Organization Nagoya Medical Center - Hematology
Nagoya, Aichi-ken, 460-0001, Japan
-
National Taiwan University Hospital - Hematology And Oncology
Taipei, 10002, Taiwan
-
Northwestern University - Feinberg School of Medicine
Chicago, Illinois, 60611, United States
-
Nottingham City Hospital - Clinical Haematology
Nottingham, NG5 1PB, United Kingdom
-
Okayama University Hospital
Okayama, 700-8558, Japan
-
Ospedale S.Maria della Misericordia, AO di Perugia, Università degli Studi di Perugia
Perugia, 06132, Italy
-
Ottawa Hospital Research Institute
Ottawa, K1H 8L6, Canada
-
PO San Gerardo, ASST Monza
Monza, 20900, Italy
-
Samsung Medical Center - Hematology-Oncology
Seoul, 06351, South Korea
-
Seoul National University Hospital - Department of Internal
Seoul, 03080, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, Seoul Teugbyeolsi, 03722, South Korea
-
Stanford University Medical Center - Cancer Clinical Trials Office - ONCOLOGY
Palo Alto, California, 94304, United States
-
The Catholic University of Korea, Seoul St. Mary's Hospital
Seoul, 06591, South Korea
-
Universiteit Maastricht Academisch Ziekenhuis Maastricht
Maastricht, 6229 HX, Netherlands
-
University College London Hospital
London, NW1 2PG, United Kingdom
-
University Health Network Princess Margaret Hospital
Toronto, M5G 1Z5, Canada
-
University Hospital - Kyoto Prefectural University of Medicine
Kyoto, 602-8566, Japan
-
University Of Colorado Cancer Center
Aurora, Colorado, 80045, United States
-
University of California San Francisco
San Francisco, California, 94143, United States
-
University of Pennsylvania Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania, 19104, United States
-
Universitätsklinikum Halle (Saale) - Klinik und Poliklinik für Innere Medizin IV
Halle, 06120, Germany
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
-
Weill Cornell Medicine
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.